Engineering SARS-CoV-2 using a reverse genetic system

Xuping Xie, Kumari G. Lokugamage, Xianwen Zhang, Michelle N. Vu, Antonio E. Muruato, Vineet D. Menachery, Pei-Yong Shi

Published: 2021-01-28 DOI: 10.1038/s41596-021-00491-8

SARS-CoV-2

reverse genetics

virus engineering

cDNA clone

COVID-19 research

浏览 1153

Supplementary information

Supplementary Information

Supplementary Fig. 1.

Reporting Summary

推荐阅读

Nature Protocols

Protocols IO

Current Protocols

In vitro reconstitution of COPII vesicles fromArabidopsis thalianasuspension-cultured cells

Anaerobic cryoEM protocols for air-sensitive nitrogenase proteins

Monomicellar assembly to synthesize structured and functional mesoporous carbonaceous nanomaterials

An optimized culture system for efficient derivation of porcine expanded potential stem cells from preimplantation embryos and by reprogramming somatic cells

Measuring DNA modifications with the comet assay: a compendium of protocols

Design and build of small-scale magnetic soft-bodied robots with multimodal locomotion

A practical guide to scanning light-field microscopy with digital adaptive optics

Reproducible mass spectrometry data processing and compound annotation in MZmine 3

Genetic in vivo engineering of human T lymphocytes in mouse models

Digital postprocessing and image segmentation for objective analysis of colorimetric reactions

查看全部

Sections

Figures

References

Supplementary information

Gralinski, L. E. & Menachery, V. D. Return of the coronavirus: 2019-nCoV. Viruses https://doi.org/10.3390/v12020135 (2020).
Muruato, A. E. et al. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat. Commun. 11, 4059 (2020).
Xie, X. et al. An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe 27, 841–848 e843 (2020).
Xie, X. et al. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat. Commun. 11, 5214 (2020).
Yount, B. et al. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl Acad. Sci. USA 100, 12995–13000 (2003).
Yount, B., Denison, M. R., Weiss, S. R. & Baric, R. S. Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J. Virol. 76, 11065–11078 (2002).
Yount, B., Curtis, K. M. & Baric, R. S. Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model. J. Virol. 74, 10600–10611 (2000).
Harcourt, J. et al. Severe acute respiratory syndrome coronavirus 2 from patient with 2019 novel coronavirus disease, United States. Emerg. Infect. Dis. https://doi.org/10.3201/eid2606.200516 (2020).
Johnson, B. A. et al. Furin cleavage site is key to SARS-CoV-2 pathogenesis. Preprint at bioRxiv https://doi.org/10.1101/2020.08.26.268854 (2020).
Plante, J. A. et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature https://doi.org/10.1038/s41586-020-2895-3 (2020).
Almazan, F. et al. Coronavirus reverse genetic systems: infectious clones and replicons. Virus Res. 189, 262–270 (2014).
Becker, M. M. et al. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc. Natl Acad. Sci. USA 105, 19944–19949 (2008).
Menachery, V. D. et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat. Med. 21, 1508–1513 (2015).
Menachery, V. D. et al. SARS-like WIV1-CoV poised for human emergence. Proc. Natl Acad. Sci. USA 113, 3048–3053 (2016).
Scobey, T. et al. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc. Natl Acad. Sci. USA 110, 16157–16162 (2013).
Sahin, U. et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature 586, 594–599 (2020).
Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589–593 (2020).
Walsh, E. E. et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2027906 (2020).
Thi Nhu Thao, T. et al. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature 582, 561–565 (2020).
Menachery, V. D. et al. Combination attenuation offers strategy for live attenuated coronavirus vaccines. J. Virol. https://doi.org/10.1128/JVI.00710-18 (2018).
Menachery, V. D. et al. MERS-CoV accessory ORFs play key role for infection and pathogenesis. mBio https://doi.org/10.1128/mBio.00665-17 (2017).
Menachery, V. D. et al. Trypsin treatment unlocks barrier for zoonotic bat coronavirus infection. J. Virol. https://doi.org/10.1128/JVI.01774-19 (2020).
Hou, Y. J. et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182, 1–18 (2020).
Curtis, K. M., Yount, B. & Baric, R. S. Heterologous gene expression from transmissible gastroenteritis virus replicon particles. J. Virol. 76, 1422–1434 (2002).

关键词

SARS-CoV-2

reverse genetics

virus engineering

cDNA clone

COVID-19 research

扫码咨询